Crow Point Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
BBHC
Crow Point Partners's NVS Position: Q2 2017 in Review
Crow Point Partners sold out of Novartis (NVS) in Q2 2017, closing a stake of 1,974 shares — an estimated $132K sold.
Crow Point Partners first reported a position in NVS in Q1 2014 and held it in 9 quarters. The position peaked at $486K in Q2 2014. 920 funds tracked by Wall St. Rank hold NVS as of Q2 2017.
- Crow Point Partners reported no remaining Novartis position as of Q2 2017 after selling out during the quarter.
- Crow Point Partners sold 1,974 Novartis shares in Q2 2017, an estimated $132K.
- Crow Point Partners first reported a position in Novartis in Q1 2014 and held it in 9 quarters.
- Crow Point Partners's Novartis position peaked at $486K in Q2 2014.
- 920 funds tracked by Wall St. Rank held Novartis as of Q2 2017.
Based on Crow Point Partners's 13F filing for Q2 2017, filed 17 Jul 2017.